Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01708252 · ClinicalTrials.gov registry record · NA

Feasibility Study: Treatment of Post-surgery and Surgery Naive Patients Who Failed to Respond to a Previous Ulthera Treatment

A NA study, sponsored by Ulthera.

Completed
Registry status
NA
Development phase
4
Enrollment target

NCT01708252: Completed NA study, sponsored by Ulthera.

NCT01708252 is a NA study that has completed, run by Ulthera. The registered enrollment target is 4 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01708252, a NA study, has completed, sponsored by Ulthera.

COMPLETED
Registry status
NA
Development phase
4 participants
Enrollment target

Study Summary

Up to 10 subjects will be enrolled. All subjects will receive an increased density UltherapyTM treatment at dual depth. Treatments will be provided to the lower 2/3 of the face and neck. Follow-up visits will occur at 90 and 180 days post-treatment. Study images will be obtained pre-treatment, 30-60 min post-treatment, and at each follow-up visit.

Primary Outcome

Efficacy will be assessed using the 90-day images compared to baseline

Interventions

  • DEVICE Ulthera System Treatment

Trial Details

FieldValue
Enrollment Target 4 participants
Start Date 2011-09
Est. Completion 2012-08
Phase NA
Ulthera

42 total trials

What the finished NCT01708252 record still lists

NCT01708252 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 1 intervention - of which Ulthera System Treatment is the first listed.

NCT01708252 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01708252 about?

NCT01708252 is a clinical study titled "Feasibility Study: Treatment of Post-surgery and Surgery Naive Patients Who Failed to Respond to a Previous Ulthera Treatment". Up to 10 subjects will be enrolled. All subjects will receive an increased density UltherapyTM treatment at dual depth. Treatments will be provided to the lower 2/3 of the face and neck. Follow-up visits will occur at 90 and 180 days post-treatment. Study images will be obtained pre-treatment, 30-60...

What is the current status of trial NCT01708252?

This trial is currently completed. It is a NA study. The enrollment target is 4 participants. The study started on 2011-09. Estimated completion is 2012-08.

What interventions are being tested in trial NCT01708252?

The interventions under investigation include: Ulthera System Treatment (DEVICE).

Who is sponsoring clinical trial NCT01708252?

This trial is sponsored by Ulthera, which has 42 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01708252's enrollment target sits among peer trials

4 1996th of 2000 higher than 5 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01708252, the US trial registry maintained by the National Library of Medicine. NCT01708252 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.